The Korean journal of internal medicine

  • 제31권2호
  • /
  • Pages.253-259
  • /
  • 2016
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Synchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome

  • Lee, Jin Seo (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Ahn, Ji Yong (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Kee Don (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Song, Ho June (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Yong Hee (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Gin Hyug (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Jung, Hwoon-Yong (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Ryu, Jin-Sook (Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Sung-Bae (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Jong Hoon (Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, Seung-Il (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Cho, Kyung-Ja (Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Jin-Ho (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine)
  • 투고 : 2014.06.18
  • 심사 : 2014.12.11
  • 발행 : 2016.03.01
⟨ 이전 논문 다음 논문 ⟩

초록

Background/Aims: Unexpected diagnosis of synchronous second primary cancers (SPC) complicates physicians' decision-making because clinical details of squamous esophageal cancer (EC) patients with SPC have been limited. We evaluated clinical features and treatment outcomes of patients with synchronous SPC detected during the initial staging of squamous EC. Methods: We identified a total of 317 consecutive patients diagnosed with squamous EC. Relevant clinical and cancer-specific information were reviewed retrospectively. Results: EC patients with synchronous SPC were identified in 21 patients (6.6%). There were significant differences in median age (70 years vs. 63 years, p = 0.01), serum albumin level (3.3 g/dL vs. 3.9 g/dL, p < 0.01) and body mass index ($20.4kg/m^2$ vs. $22.8kg/m^2$, p = 0.01) between EC patients with and without SPC. Head and neck, lung and gastric cancers accounted for 18.2%, 22.7%, and 18.2% of SPC, respectively. Positron emission tomography-computed tomography (PET-CT) detected four cases (18.2%) of SPC that were missed on CT. Management plans were altered in 13 of 21 patients (61.9%) with detected SPC. Curative esophagectomy was attempted in 28.6% of EC patients with SPC (vs. 59.1% of patients without SPC; p = 0.006). EC patients with SPC had significantly lower 5-year survival than patients without SPC (10.6% vs. 36.7%, p = 0.008). Conclusions: Synchronous SPC were found in 6.6% of squamous EC patients, and PET-CT contributed substantially to the detection of synchronous SPC. EC patients with SPC had poor survival due to challenges of providing stage-appropriate treatment.

키워드

참고문헌

  1. Koide N, Yazawa K, Koike S, Adachi W, Amano J. Oesophageal cancer associated with other primary cancers: a study of 31 patients. J Gastroenterol Hepatol 1997;12:690-694. https://doi.org/10.1111/j.1440-1746.1997.tb00536.x
  2. Nagasawa S, Onda M, Sasajima K, Takubo K, Miyashita M. Multiple primary malignant neoplasms in patients with esophageal cancer. Dis Esophagus 2000;13:226-230. https://doi.org/10.1046/j.1442-2050.2000.00116.x
  3. Poon RT, Law SY, Chu KM, Branicki FJ, Wong J. Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications. Ann Thorac Surg 1998;65:1529-1534. https://doi.org/10.1016/S0003-4975(98)00177-5
  4. Shibuya H, Wakita T, Nakagawa T, Fukuda H, Yasumoto M. The relation between an esophageal cancer and associated cancers in adjacent organs. Cancer 1995;76:101-105. https://doi.org/10.1002/1097-0142(19950701)76:1<101::AID-CNCR2820760115>3.0.CO;2-D
  5. Chuang SC, Scelo G, Tonita JM, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev 2008;17:1543-1549. https://doi.org/10.1158/1055-9965.EPI-07-2876
  6. Matsubara T, Yamada K, Nakagawa A. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003;21:4336-4341. https://doi.org/10.1200/JCO.2003.12.074
  7. Park EK, Kwon JH, Lee JH, Lee SJ. Clinical study of multiple primary malignant tumor. Korean J Med 2005;69:410-418.
  8. Choi JY, Lee KS, Kwon OJ, et al. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol 2005;23:7654-7659. https://doi.org/10.1200/JCO.2005.01.4340
  9. Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 2005;46:752-757.
  10. van Westreenen HL, Westerterp M, Jager PL, et al. Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer. J Nucl Med 2005;46:1321-1325.
  11. Warren S. Multiple primary malignant tumors. Am J Cancer 1932;16:1358-1414.
  12. Greene F, Page D, Fleming I. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag, 2002.
  13. Ajani J, D'Amico TA, Hayman JA, Meropol NJ, Minsky B; National Comprehensive Cancer Network. Esophageal cancer: clinical practice guidelines in oncology. J Natl Compr Canc Netw 2003;1:14-27. https://doi.org/10.6004/jnccn.2003.0004
  14. Kim JH, Choi EK, Kim SB, et al. Preoperative hyperfractionated radiotherapy with concurrent chemotherapy in resectable esophageal cancer. Int J Radiat Oncol Biol Phys 2001;50:1-12. https://doi.org/10.1016/S0360-3016(01)01459-6
  15. Lee JL, Park SI, Kim SB, et al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 2004;15:947-954. https://doi.org/10.1093/annonc/mdh219
  16. Kim MK, Kim SB, Ahn JH, et al. Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 2008;71:725-734. https://doi.org/10.1016/j.ijrobp.2007.10.009
  17. Gandini S, Botteri E, Iodice S, et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer 2008;122:155-164. https://doi.org/10.1002/ijc.23033
  18. van Westreenen HL, Westerterp M, Bossuyt PM, et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 2004;22:3805-3812. https://doi.org/10.1200/JCO.2004.01.083
  19. Rosenbaum SJ, Stergar H, Antoch G, Veit P, Bockisch A, Kuhl H. Staging and follow-up of gastrointestinal tumors with PET/CT. Abdom Imaging 2006;31:25-35. https://doi.org/10.1007/s00261-005-0031-3
  20. Kleinberg L, Forastiere AA. Chemoradiation in the management of esophageal cancer. J Clin Oncol 2007;25:4110-4117. https://doi.org/10.1200/JCO.2007.12.0881
  21. Kim YJ, Kim JY, Do YR, Song HS, Kim OB. The efficacy of concurrent chemoradiotherapy for patients with inoperable esophageal cancer. Korean J Med 2007;72:37-43.
  22. Lee GD, Kim YH, Kim JB, et al. Esophageal cancer associated with multiple primary cancers: surgical approaches and long-term survival. Ann Surg Oncol 2013;20:4260-4266. https://doi.org/10.1245/s10434-013-3183-3
  23. Di Fiore F, Lecleire S, Pop D, et al. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 2007;102:2557-2563. https://doi.org/10.1111/j.1572-0241.2007.01437.x

피인용 문헌

  1. What should we expect from robotic surgery for second primary oropharyngeal cancer? vol.274, pp.8, 2017, https://doi.org/10.1007/s00405-017-4594-8
  2. Chemoradiotherapy for Synchronous Multiple Primary Cancers with Esophageal Squamous Cell Carcinoma: a Case-control Study vol.8, pp.4, 2016, https://doi.org/10.7150/jca.17408
  3. Synchronous Supraglottic and Esophageal Squamous Cell Carcinomas Treated with a Monoisocentric Hybrid Intensity-Modulated Radiation Technique vol.7, pp.None, 2016, https://doi.org/10.3389/fonc.2017.00307
  4. 18 F-fluorodeoxyglucose positron emission tomography-computed tomography as a screening tool for second primary cancers in cancer patients vol.8, pp.54, 2016, https://doi.org/10.18632/oncotarget.21444
  5. Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers: A Retrospective Single-institution Study vol.267, pp.3, 2016, https://doi.org/10.1097/sla.0000000000002118
  6. Long-Term Survival and Tumor Recurrence in Patients with Superficial Esophageal Cancer after Complete Non-Curative Endoscopic Resection: A Single-Center Case Series vol.51, pp.5, 2016, https://doi.org/10.5946/ce.2018.025
  7. Second primary malignancy in patients with esophageal adenocarcinoma and squamous cell carcinoma vol.98, pp.36, 2016, https://doi.org/10.1097/md.0000000000017083
  8. Synchronous resection of esophageal cancer and other organ malignancies: A systematic review vol.25, pp.26, 2019, https://doi.org/10.3748/wjg.v25.i26.3438
  9. Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: a nationwide study in a Western population vol.9, pp.4, 2016, https://doi.org/10.1177/2050640620977129
  10. Clinical analysis of 117 cases with synchronous multiple primary esophageal squamous cell carcinomas vol.36, pp.6, 2016, https://doi.org/10.3904/kjim.2017.280